R. Daniel Chevallard

Affiliations

  • Chief Financial Officer at Lenz Therapeutics Inc. (LENZ), 2025-01-13
  • Cfo And Coo at Viracta Therapeutics Inc. (VIRX), 2024-03-14
  • Chief Financial Officer at Regulus Therapeutics Inc. (RGLS), 2019-07-02
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
LENZ $15.68 3,188 $49,987.84 3,188 2024-05-14 Filing
RGLS $0.91 54,945 $49,999.95 59,415 2017-07-25 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
VIRX $0.73 3,405 $2,493.14 102,306 2024-02-27 Filing
VIRX $0.50 3,720 $1,860.00 98,822 2023-11-28 Filing
VIRX $1.45 3,512 $5,092.40 95,653 2023-08-28 Filing
VIRX $1.42 3,635 $5,160.25 92,277 2023-05-25 Filing
VIRX $1.68 3,599 $6,050.64 89,023 2023-02-27 Filing